Today's Date: December 3, 2022
Canada Revenue Agency's Disability Advisory Committee submits 10 recommendations in its third annual report   •   Jack Nathan Health Provides Corporate Update   •   EHEALTH INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Of   •   GENERAC HOLDINGS SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losse   •   PROVIDENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Provident Bancorp, Inc. on Behalf of Provident Stockholders an   •   Bark Technologies Announces a Strategic MVNO Agreement with T-Mobile Enabling Mobile Service for its Bark Phone Featuring Childr   •   Ismael Cala invites you to plan and manifest 2023 as the best year of our lives   •   'Tis the Season for Giving Back at Jim Ellis Automotive   •   PAYPAL HOLDINGS, INC. DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Fil   •   Leading National Prostate Cancer Nonprofit Spearheads Influential HHS Moonshot Meeting   •   Reducing licensed child care fees for British Columbia families by 50%   •   The Canadian Association of Journalists is now accepting nominations for its 2022 Awards program   •   Dennis Amos, Vice President of Planning & Analysis for The Twenty-Nine Palms Band of Mission Indians, "QCI's Dynamic Reinves   •   The Law Offices of Frank R. Cruz Announces Investigation of Generac Holdings Inc. (GNRC) on Behalf of Investors   •   MSCI Uplifted GTJAl's ESG Rating, Stating That Its Corporate Governance Leads Global Peers   •   OPENDOOR DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Op   •   INVESTOR DEADLINE: Olaplex Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit &ndash   •   Louisiana local Ronnie Schwartz clinches St. Jude Hero Among Us Award   •   Savory & Partners: Birthright citizenship and the exciting world of birth tourism   •   GENERAC ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Generac Holdings, In
Bookmark and Share

Whitsett Vision Group First to Use Revolutionary New Lens to Dramatically Improve Patients' Eyesight

Whitsett Vision Group First to Use Revolutionary New Lens to Dramatically Improve Patients' Eyesight

PR Newswire

HOUSTON, Sept. 26, 2022 /PRNewswire/ -- Whitsett Vision Group announced today it is the first ophthalmologist group in the country to perform cataract surgeries using a new lens approved by the Food and Drug Administration (FDA) and that the practice has added another lens to its patient offerings. Both lenses have been shown to improve patients' vision and overall quality of life.

The two new lenses include the Lenstec ClearView 3, a multifocal intraocular lens, and the RxSight Light Adjustable Lens (LAL). 

"Through recent advancements and technology, we can correct cataracts and enhance our patients' quality of life as we've never been able to before," said Jeffery Whitsett, board-certified ophthalmologist, and founder of the Whitsett Vision Group and VISTA Ophthalmics.

In clinical trials, patients reported having high-quality distance and near vision after receiving the ClearView 3 lens. They also did not experience dysphotopia, a common condition after cataract surgery, which is best described as the appearance of arcs, streaks, starbursts, or rings. 

"The ClearView 3 from Lenstec has been designed with increased precision, accuracy, and stability, which results in excellent long-term visual outcomes at near, intermediate, and distance," said Whitsett. 

Whitsett and his team performed the first surgeries using ClearView 3 as recently as Aug. 15. 

The LAL lens is another option for Whitsett Vision Group's patients and is the only intraocular lens that enables ophthalmologists to customize a patient's vision after cataract surgery. 

"This lens allows us to customize vision for each patient and adjust after surgery during a routine appointment. It can be adjusted to meet every patient's lifestyle needs and allows them to essentially 'test drive' the lens to experience and design their best visual outcome with complete confidence," said Whitsett.

Studies show that patients receiving the LAL and the recommended post-surgery treatments were more likely to achieve 20/20 vision or better without glasses than cataract patients with standard lens implants.

Surgeries using the LAL lens at Whitsett Vision Group started in late August. 

Whitsett, who has helped pioneer ophthalmology research for new devices, procedures, and medications, was heavily involved in the FDA trials for the ClearView 3. 

For more information about Whitsett Vision Group, visit

Images, videos, and background images are available here.

About Whitsett Vision Group 

Whitsett Vision Group was founded in 1999 by Dr. Jeffrey Whitsett to bring superior eye care and surgical vision treatment options to the city of Houston. Since its inception, Whitsett Vision Group has been focused on custom cataract and LASIK surgery, utilizing advanced technologies and innovative lens solutions to provide patients with the best visual outcomes after surgery. More information about Whitsett Vision Group is available at

Media Contact:                                                                                

Laura Frnka-Davis

LFD Communications for Whitsett Vision Group


Cision View original content to download multimedia:

SOURCE Whitsett Vision Group

Back to top
| Back to home page

White House Live Stream
Breaking News
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Sounds Make the News ®
Atlanta - WAOK-Urban
Berkley / San Francisco - KPFA-Progressive
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
Washington - WOL-Urban

Listen to United Natiosns News